Citric Acid

If you have ever passed a kidney stone, or worry you might, the level of citrate in your urine is one of the most useful numbers you can know. It is a built-in defense system: citrate binds to calcium in your urine and blocks the crystals that form stones.

When this number drops, your urine loses one of its main brakes on stone formation. Low urinary citrate is one of the most consistent findings in people who form calcium stones, and it can also reflect deeper issues with how your kidneys handle acid load.

What This Test Actually Measures

Citric acid is a small organic acid produced in the energy-making compartments inside your cells (called mitochondria) through a chain of reactions known as the citric acid cycle. Your kidneys filter it out of your blood, then reabsorb most of it back through tubes called proximal tubules. What is left over ends up in your urine.

The amount that stays in your urine depends heavily on your body's acid-base balance. When your blood tilts toward acidic, your kidneys grab more citrate back, and your urine level drops. When you tilt toward alkaline, more citrate spills into your urine. Diet, kidney function, potassium status, and certain medications all shift that balance.

Calcium Kidney Stone Risk

This is the headline reason to know your number. In a large analysis of stone formers, higher urinary citrate was associated with a lower risk of forming kidney stones, while lower levels tracked with higher risk. Citrate works by chelating calcium (forming soluble complexes that cannot crystallize) and by directly blocking the growth of calcium oxalate and calcium phosphate crystals.

Low citrate (a condition called hypocitraturia) is present in roughly 20 to 60 percent of people who form calcium stones, making it one of the most common modifiable metabolic risk factors. In Korean young adults with stones, those with the lowest urinary citrate had a meaningfully higher risk of stone recurrence, with citrate excretion emerging as an independent predictor. Calcium phosphate stone formers, in particular, tend to show both higher urine pH and lower citrate than calcium oxalate stone formers.

What this means for you: if you have already had one stone, knowing your citrate level gives you a specific lever to pull. People with low values can often more than double their urinary citrate through dietary alkali or potassium citrate therapy, and many shift back into the protective range. A Cochrane review found that citrate therapy substantially reduced new stone formation (relative risk 0.26).

Chronic Kidney Disease Signals

Urinary citrate is also a window into early kidney trouble. Studies of people with non-diabetic chronic kidney disease (CKD) show reduced urinary excretion of citrate and other related metabolites, with kidney biopsies revealing reduced activity in the same energy pathway. In diabetic CKD, lower urinary citric acid and a related molecule called aconitic acid were linked to faster decline in kidney filtration and a higher risk of progressing to kidney failure.

In a cohort of people with type 2 diabetes, urine citrate predicted the risk of progression to end-stage kidney disease independent of standard clinical risk factors. In a separate CKD cohort, urinary metabolites including citrate were significant predictors of disease progression.

There is also a quieter signal: in people with early CKD who do not yet have full-blown metabolic acidosis (a state where the body is holding onto too much acid), lower urine citrate flags acid retention before it shows up on routine blood panels. Researchers have proposed using urine citrate, and the spot urinary citrate-to-creatinine ratio, as a non-invasive marker of this acid buildup and as a guide to starting alkali therapy.

Post-Bariatric Surgery and Transplant Stones

Roux-en-Y gastric bypass, one of the most common weight-loss surgeries, reduces urinary citrate substantially (around 40 to 60 percent in published studies) and is associated with a higher kidney stone risk afterward (pooled relative risk about 1.79 in a systematic review). Sleeve gastrectomy appears to carry less risk, with citrate excretion generally remaining stable after that procedure. In kidney transplant recipients who develop stones, hypocitraturia and high oxalate were the dominant metabolic abnormalities, with nearly every tested patient showing very low citrate values.

Hypertension and Vascular Calcification

In a study of more than 3,000 adults (a combined cohort of 3,024 participants), lower urinary citrate excretion was independently associated with having high blood pressure, suggesting that the systems regulating citrate may overlap with those regulating vascular health. Separately, people with calcium buildup in their abdominal aorta were more likely to have low citrate and low urine pH (odds ratio about 4.37 for hypocitraturia), hinting at a shared acid-handling problem across the kidneys and blood vessels.

Bone Health

In nearly 9,000 patients with kidney stone disease, hypocitraturia was a modest risk factor for osteoporosis or fracture. The link is not large, and other factors (such as high urinary calcium) likely explain most of the connection between stones and weaker bones, but it points to the broader role of chronic acid load in pulling minerals out of bone.

Sex, Age, and Menopause

Urinary citrate varies with age and sex. In healthy children, levels differ by age and gender, with higher values in girls during puberty. Postmenopausal women have slightly lower citrate and a higher risk of kidney stones than premenopausal women, and a study of stone formers found that urinary androgens and estrogens were significantly associated with calcium and citrate excretion.

Why One Reading Is Not Enough

Urinary citrate is one of the most variable solutes in urine. In a meta-analysis of urine composition, citrate showed wide variability among major components, largely because it responds so quickly to diet and acid-base status. A single measurement can be thrown off by what you ate yesterday.

In a study of metabolic evaluation, a second 24-hour urine collection changed the clinical interpretation in up to 45% of patients compared with a single collection. Major guidelines (AUA and ACP) recommend repeat collections. The practical translation: get a baseline, repeat in 3 to 6 months if you are changing your diet or starting treatment, and recheck at least annually if you are actively managing stone risk. The value comes from watching how your number moves with what you do, not from any single snapshot.

When Results Can Be Misleading

Because citrate shifts so easily with what passes through your kitchen, a few short-term factors can distort a single reading. Lemon juice, melon, orange juice, and other citrus or alkaline fruits acutely raise urinary citrate within days, so a single high reading after a week of citrus intake may not reflect your usual state. Conversely, a high-protein or high-sodium load before testing can transiently push numbers down. Potassium deficiency is itself an independent driver of low urinary citrate.

• Recent diet shifts: heavy citrus or alkaline fruit intake within the days before collection can transiently raise citrate; high animal protein or salt can push it down.
• Incomplete 24-hour collection: missing even one urine void during a 24-hour collection produces falsely low totals that look like hypocitraturia.
• Acute illness or dehydration: short-term acid-base shifts during illness can alter results without reflecting your usual physiology.
• Potassium depletion: low body potassium (from diuretics, vomiting, diarrhea, or poor intake) lowers urinary citrate independent of stone biology.
• Topiramate: this anti-seizure and migraine medication lowers urinary citrate as a known side effect; the change can mimic hypocitraturia without indicating a primary kidney stone disorder.

What an Abnormal Result Should Trigger

If your urinary citrate comes back low, the next step is not panic but pattern recognition. Pair it with the rest of the 24-hour urine panel: calcium, oxalate, uric acid, sodium, volume, and pH together paint the real picture. A low citrate combined with high urine pH points toward calcium phosphate physiology; low citrate with normal pH and high calcium suggests a calcium oxalate pattern. A simultaneously low serum bicarbonate or a low eGFR (a measure of how well your kidneys filter) raises the question of early CKD-related acid retention.

Repeat the collection at least once to confirm, since a single value can mislead. If hypocitraturia is real and persistent, consider involving a nephrologist or stone-prevention specialist, especially if you have a history of recurrent stones, transplant, bariatric surgery, or known CKD. The treatment lever, alkali therapy, is well-established, but the right dose and form depend on the full picture of your urine chemistry, kidney function, and stone composition. Potassium citrate in particular needs caution in two situations: calcium phosphate stone formers (because raising urine pH can increase calcium phosphate supersaturation) and people with advanced CKD or other reasons for high blood potassium.